Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosimetry and Safety of Technetium Tc99m Sestamibi in Pediatric Subjects
NCT00162045Phase 2Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Jan 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of technetium-99m sestamibi in Kawasaki disease (KD), sponsored by Lantheus Holdings, Inc.. Started Jan 2005; status: completed.
02
Drugs
technetium-99m sestamibi
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT00162045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162045.